NorthWest Biotherapeutics Inc (NWBO)

[Poor Man -]

Because of the lack of visibility, we really don’t know whether she and Toucan benefitted from that 2021 sale or not.

The problem with the discounted shares and warrants that have been a feature of NWBO funding is that it dilutes common retail shareholders. That’s why the share price has declined to a four year low, yet the market cap has remained more or less within a range over that period.